Modified-release recombinant human TSH (MRrhTSH) augments the effect of 131I therapy in benign multinodular goiter: Results from a multicenter international, randomized, placebo-controlled study

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1368-1376

  Graf, Hans ^a   Fast, S ^b   Pacini, F ^c   Pinchera, A ^d   Leung, A ^e   Vaisman, M ^f   Reiners, C ^g   Wemeau, J L ^h   Huysmans, D ⁱ   Harper, W ^j   Driedger, A ^k   Noemberg De Souza, H ^a   Castagna, M G ^c   Antonangeli, L ^d   Braverman, L ^e   Corbo, R ^f   Duren C ^g   Proust Lemoine, E ^h   Edelbroek, M A ⁱ   Marriott, C ^j   Rachinsky, I ^k   Grupe, P ^b   Watt, T ^l   Magner, J ^m   Hegedus, L ^b   more..

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ CATHARINA HOSPITAL   (Netherlands)

^j HAMILTON GENERAL HOSPITAL   (Canada)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

^l Rigshospitalet   (Denmark)

^m GENZYME CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PLACEBO; RECOMBINANT THYROTROPIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; DRUG RELEASE; DRUG RESPONSE; DRUG SAFETY; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTINODULAR GOITER; NECK PAIN; NODULAR GOITER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYROID WEIGHT; TRACHEA;

EID: 79955680562     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1193     Document Type: Article

References (33)

1. Hegedüs L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132 (Pubitemid 36223282)
2. Bonnema SJ, Nielsen VE, Hegedüs L 2004 Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. Eur J Endocrinol 150:439-445 (Pubitemid 38584693)
3. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 AACE/AME/ETA Task Force on Thyroid Nodules of the American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468-475
4. Fast S, Bonnema SJ, Hegedus L 2008 The majority of Danish non-toxic goitre patients are ineligible for Levothyroxine suppressive therapy. Clin Endocrinol (Oxf) 69:653-658
5. Wesche MF, Tiel-V Buul MM, Lips P, Smits NJ, Wiersinga WM 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998-1005 (Pubitemid 32322972)
6. Cooper DS, DohertyGM,Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
7. Hegedüs L, Hansen BM, Knudsen N, Hansen JM 1988 Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 297:661-662
8. Nygaard B, Hegedüs L, GervilM,Hjalgrim H, Soe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. BMJ 307:828-832 (Pubitemid 23281746)
9. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
10. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinanthumanTSHchanges the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330-5336 (Pubitemid 33070255)
11. Nieuwlaat WA,Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129 (Pubitemid 36877482)
12. Braverman L, Kloos RT, Law Jr B, Kipnes M, Dionne M, Magner J 2008 Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. Endocr Pract 14:832-839
13. Nielsen VE, Bonnema SJ, Hegedüs L 2004 Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 89:2242-2247 (Pubitemid 38619859)
14. Pena S, Arum S, Cross M, Magnani B, Pearce EN, Oates ME, Braverman LE 2006 123I uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab 91:506-510 (Pubitemid 43236916)
15. Bonnema SJ, Nielsen VE, Boel-Jorgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L 2007 Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a doubleblinded, randomized trial. J Clin Endocrinol Metab 92:3424-3428 (Pubitemid 47435314)
16. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Grupe P, Hegedüs L 2006 Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 166:1476-1482 (Pubitemid 44125866)
17. Silva MN, Rubio IG, Romao R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G 2004 Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 60:300-308 (Pubitemid 38297119)
18. Fast S, Nielsen VE, Bonnema SJ, Hegedüs L 2010 Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function. Comparison of 0.1, 0.3 and 0.9 mg of rhTSH. Clin Endocrinol (Oxf) 72:411-416
19. Nielsen VE, Bonnema SJ, Hegedüs L 2006 Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J Clin Endocrinol Metab 91:1317-1322
20. Fast S, Nielsen VE, Bonnema SJ, Hegedüs L 2009 Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 160:517-528
21. Magner JA, Kipnes MS, Kloos RT, Law BM, Braverman LE Cardiac effects of thyrogen (rhTSH) in multinodular goiter (MNG) patients: a cautionary note. Proc of the 77th Annual Meeting of the American Thyroid Association, 2006 Phoenix, Arizona, p 269 (Abstract 236)
22. Watt T, Hegedüs L, Groenvold M, Bjorner JB, Rasmussen AK, Bonnema SJ, Feldt-Rasmussen U 2010 Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 162:161-167
23. Geffner DL 1989 Symptom rating scale for assessing hyperthyroidism. Arch Intern Med 149:1466-1467
24. Fast S, Hegedüs L, Grupe P, Nielsen VE, Bluhme C, Bastholt L, Bonnema SJ 2010 Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab 95:3719-3725
25. Bonnema SJ, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L 2008 Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. J Clin Endocrinol Metab 93:3981-3984
26. Albino CC, Graf H, Paz-Filho G, Diehl LA, Olandoski M, Sabbag A, Buchpiguel C 2010 Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter. Braz J Med Biol Res 43:303-309
27. Paz-Filho GJ, Mesa CO, Carvalho GA, Goedert CA, Graf H 2008 Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years. Clin Endocrinol (Oxf) 69:345-346 (Pubitemid 352009013)
28. Bonnema SJ, Hegedüs L 2009 A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter. Curr Opin Endocrinol Diabetes Obes 16:379-384
29. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A 1998 Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83: 40-46 (Pubitemid 28498308)
30. Stensvold AD, Jorde R, Sundsfjord J 1997 Late and transient increases in free T4 after radioiodine treatment for Graves' disease. J Endocrinol Invest 20:580-584 (Pubitemid 28026554)
31. Nygaard B, Knudsen JH, Hegedüs L, Scient AV, Hansen JE 1997 Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82:2926-2930 (Pubitemid 27385650)
32. Paz-Filho GJ, Mesa-Junior CO, Olandoski M, Woellner LC, Goedert CA, Boguszewski CL, Carvalho GA, Graf H 2007 Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz J Med Biol Res 40:1661-1670
33. Hegedüs L, Bonnema SJ 2010 Approach to the management of the patient with primary or secondary intrathoracic goiter. J Clin Endocrinol Metab 95:5155-5162